Drug Shortage Report for NAT-EVEROLIMUS
Report ID | 241868 |
Drug Identification Number | 02530120 |
Brand name | NAT-EVEROLIMUS |
Common or Proper name | Everolimus |
Company Name | NATCO PHARMA (CANADA) INC |
Market Status | MARKETED |
Active Ingredient(s) | EVEROLIMUS |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 UD BLS |
ATC code | L04AH |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-11-01 |
Estimated end date | 2025-01-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-11-02 | English | Compare |
v2 | 2024-11-01 | French | Compare |
v1 | 2024-11-01 | English | Compare |
Showing 1 to 3 of 3